Lifebank
Lifebank is a US-based private stem cell bank (subsidiary of Celularity) that collects, processes, and cryopreserves newborn cord blood and placental tissue for individual family storage. It serves expectant parents via direct-to-consumer sales and OBGYN/midwife referrals, with patented placental processing as its core differentiator.
- Company typePrivate
- Founded1998
- HeadquartersFlorham Park, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Lifebank does
Lifebank (legal entity: Celularity Inc. d/b/a LifebankUSA) is a US-based private stem cell banking company that collects, processes, and cryopreserves hematopoietic stem cells from umbilical cord blood and mesenchymal stem cells from placental blood and tissue for individual family storage. Founded in 1998, acquired by Celgene in 2002, and spun out as Celularity in 2017 with Lifebank retained as a core subsidiary, the company operates a state-of-the-art processing and storage facility in Florham Park, NJ, alongside a Cedar Knolls headquarters. Its patented processing methods for placental blood and tissue preservation are described as unique to the company, with Celularity research indicating a 68% increase in CD34+ cells and 17% increase in TNC when adding placental banking to cord blood alone. The product line includes Cord Blood Banking ($1,274 first-year / $199 annual storage), a comprehensive Cord + Placental Blood and Tissue Package ($3,024 first-year / $449 annual storage), a Sibling Program offering free or discounted services to families with children diagnosed with qualifying diseases (in partnership with Duke University and MD Anderson), and a Donation Program supplying biomaterials for Celularity's cellular therapy research.
The business model is a hybrid direct-to-consumer and healthcare-professional-referred sales motion: expectant parents enroll via the company website (myaccount.lifebankusa.com), phone (877-543-3226), or scheduled Client Services planning sessions, while OBGYNs, midwives, and hospital staff act as both referral sources and the on-site collection channel at delivery. Revenue mechanics combine a one-time enrollment and processing fee ($900–$2,400) with a recurring annual storage annuity ($199–$449) running up to 18 years or longer, creating a long-duration revenue tail per customer. The Sibling Program and Donation Program extend the funnel into specialized medical use cases (blood-related disorders, Cerebral Palsy, Autism) and supply Celularity's regenerative medicine pipeline, including products such as Interfyl and Biovance. Customer segments span expectant parents (primary), healthcare professionals (collection channel), families with diagnosed children (specialized), and placenta donors (research supply). Distribution is US-only with no international presence. The company has reported 99%+ customer satisfaction and 25+ years of operating history, supported by media coverage in Fox Business, NBC, CBS, the Wall Street Journal, the New York Times, and Science AAAS.
Lifebank firmographics
Firmographics- Name
- Lifebank
- Legal name
- Celularity Inc. d/b/a LifebankUSA
- Website
- https://lifebankusa.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Lifebank is a US-based private stem cell bank (subsidiary of Celularity) that collects, processes, and cryopreserves newborn cord blood and placental tissue for individual family storage. It serves expectant parents via direct-to-consumer sales and OBGYN/midwife referrals, with patented placental processing as its core differentiator.
- Ownership category
- akta.pro rank
Lifebank industry classification
Industry- Product category
- Stem Cell Banking
- NAICS
- Blood and Organ Banks (621991)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)
- akta.pro secondary industries
- Stem Cell Therapies (MSC/iPSC/HSC-derived) (HLAAABAE), Cell Banking & Viral Seed Services (MCB/WCB/VSB) (HLAGAGAD), Blood, Organ & Tissue Donation Organizations (BPAGACAJ)
Keywords
Where Lifebank is headquartered
LocationHeadquarters
- HQ city
- Florham Park
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Lifebank business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales, Technology or R&D
Revenue model
- Cord Blood Banking Enrollment and Processing: One-time enrollment and processing fees for cord blood banking services. First-year costs total $1,274 including a $175 non-refundable registration fee, $900 enrollment and processing fee, and $199 annual storage fee.
- Annual Storage Fees: Recurring annual storage fees for cryopreserved stem cells. Annual storage costs $199 for cord blood alone, totaling $3,582 over 18 years or $3,000 if paid upfront.
- Placental Blood and Tissue Banking: Enhanced banking service combining cord blood with placental blood and tissue. First-year costs $3,024 including $2,400 enrollment and processing fee plus $449 annual storage. Storage totals $8,082 over 18 years or $7,599 upfront.
- Placenta Donation Program: Free donation program for eligible clients who meet criteria and donate placenta. Enrollment and processing fee of $500 for qualified donors.
- Sibling Program Services: Discounted or free services for families with children diagnosed with certain diseases. Traditional program offers free collection, processing, and 5 years storage. Cerebral Palsy and Autism program offers 50% off collection and processing fees.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Annual | Cord Blood Banking - Basic |
| One time/ perpetual license | Annual | Placenta Donation Program |
| One time/ perpetual license | Annual | Cord + Placental Blood + Tissue Comprehensive Banking |
| Subscription | Annual | Sibling Program - Traditional (Blood Related Disorders) |
| Subscription | Annual | Sibling Program - Cerebral Palsy and Autism Spectrum Disorder |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels8 records
Lifebank product offering
Product offeringCore offering
Lifebank collects, processes, and cryopreserves hematopoietic stem cells from umbilical cord blood and mesenchymal stem cells from cord tissue, placental blood, and placental tissue for expectant parents. Services are sold as private banking packages, a comprehensive cord-plus-placental package, a discounted Sibling Program for families with affected children, and a Donation Program for public/research contribution, with materials stored at the company's Florham Park, NJ facility.
Product overview
Lifebank is a stem cell banking company offering a family of cord blood and placental banking services. The core offering consists of Cord Blood Banking, which preserves hematopoietic stem cells (HSCs) from umbilical cord blood for treating over 80 FDA-approved diseases. Placental Banking complements this by preserving additional stem cells from placental blood and tissue, including mesenchymal stem cells (MSCs) with regenerative medicine potential. These can be purchased individually or as a combined Cord Blood + Placental Blood and Tissue Package. Lifebank also offers a Sibling Program for families with qualifying medical conditions at discounted rates, and a Donation Program for families choosing to contribute to public stem cell supplies. The company operates under Lifebank By Celularity, leveraging Celularity's patented technologies and state-of-the-art processing and storage facilities in New Jersey.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- 68% increase in CD34+ stem cells when adding placental blood banking to cord blood banking
- +4 more outcomes
Companies that use Lifebank
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles2 records
Lifebank technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Lifebank partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and flagship.
- CelularitycoreLifebank is a subsidiary of Celularity Inc., which was spun out from Celgene in 2017. Celularity provides scientific leadership, research capabilities, and advanced cellular therapy development. Robert J. Hariri, M.D., Ph.D. serves as Founder, Chairman, and CEO of Celularity and Lifebank. Lifebank operates as Lifebank By Celularity.
- Duke UniversityflagshipDuke University has an Expanded Access Protocol for the use of umbilical cord blood infusions to treat children with Cerebral Palsy and Autism. Lifebank's Sibling Program for Cerebral Palsy and Autism offers 50% off services for families participating in this protocol.
- MD Anderson Cancer CenterflagshipMD Anderson has an Expanded Access Protocol for umbilical cord blood infusions to treat Cerebral Palsy and Autism. Partnered with Lifebank's Sibling Program to provide discounted stem cell banking services.
- Children's Hospital New Orleans / LSUHSCflagshipDr. Lolie Yu at LSUHSC & Children's Hospital performed the world's first combined cord and placental stem cell transplant in 2008 using Lifebank-processed stem cells for Quentin's treatment of acute lymphoblastic leukemia.
Scale indicators7 records
Recent moves8 records
Expansion highlights4 records
Lifebank competitors and assessment
Company assessmentDirect peers
- StemCyte: StemCyte operates both private and public cord blood banking services with an emphasis on cord blood and placental tissue processing. It is a direct competitor in placental-derived stem cell banking, the same differentiated product category where Lifebank holds its patented technology advantage.
- AlphaCord: AlphaCord is a US-based private cord blood bank offering cord blood and tissue banking services to expectant parents. It is a smaller direct peer competing in the same niche private banking segment with similar pricing structures and recurring storage revenue model.
- Cryo-Cell International: Cryo-Cell International is a publicly-traded cord blood banking company offering services similar to Lifebank's core cord blood banking product. It competes in the same DTC private banking market with comparable pricing, processing technology, and recurring storage revenue model.
- ViaCord: ViaCord is a leading private cord blood and cord tissue bank owned by Revvity (formerly PerkinElmer). It directly competes with Lifebank on cord blood banking for expectant parents with comparable pricing tiers, recurring storage fees, and a similar healthcare professional referral GTM motion.
- Cord Blood Registry (CBR): Cord Blood Registry is the largest US private cord blood bank, offering cord blood and cord tissue preservation services to expectant parents. CBR is the most direct competitor to Lifebank, operating with a similar DTC sales model, healthcare professional referral network, and recurring storage revenue structure.
Regional players
- Cells4Life: Cells4Life is the UK's largest private cord blood bank, offering cord blood and tissue storage across multiple international markets. It is comparable to Lifebank in product offering and service tiers but operates in different geographies, serving as a relevant peer for international expansion benchmarking.
- Smart Cells International: Smart Cells is a UK-based private stem cell bank offering cord blood and tissue banking services with international shipping. It is comparable to Lifebank as a private banking competitor serving expectant parents with a similar subscription-based storage model, but operates primarily outside the US.
Broad incumbents
- Celularity Inc. Celularity is Lifebank's parent company and a broader cellular therapy biotech developing placental-derived therapeutics including Interfyl and Biovance. While not a peer in the traditional sense, Celularity is highly relevant as the integrated platform that owns and operates Lifebank and could expand into adjacent regenerative medicine services.
Emerging players
- Cleveland Cord Blood Center: Cleveland Cord Blood Center is a public cord blood bank and research organization collecting donations for transplant and research use. It serves as an adjacent peer representing the public banking model that competes with Lifebank's donation program and broader private banking value proposition.
- New York Blood Center: New York Blood Center operates one of the largest public cord blood banks in the US, including the National Cord Blood Program. While not a direct private competitor, it is a relevant adjacent player representing the public banking alternative that competes for consumer mindshare against Lifebank's private offering.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Lifebank social profiles
Digital presenceLifebank financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lifebank leadership team
Management profileNumber of profiles
Profiles1 record
Lifebank funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lifebank M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lifebank
What does Lifebank do?
Lifebank collects, processes, and cryopreserves hematopoietic stem cells from umbilical cord blood and mesenchymal stem cells from cord tissue, placental blood, and placental tissue for expectant parents. Services are sold as private banking packages, a comprehensive cord-plus-placental package, a discounted Sibling Program for families with affected children, and a Donation Program for public/research contribution, with materials stored at the company's Florham Park, NJ facility.
Is Lifebank a public or private company?
Lifebank is a private company. It is classified as corporate owned and is currently operating.
When was Lifebank founded?
Lifebank was founded in 1998. It employs 11 to 50 people.
Where is Lifebank based?
Lifebank is headquartered in Florham Park, United States, in the North America region.
How does Lifebank make money?
Five revenue lines are on record. Cord Blood Banking Enrollment and Processing is the primary driver. The others are annual Storage Fees, placental Blood and Tissue Banking, placenta Donation Program and sibling Program Services.
Who are Lifebank's main competitors?
Direct peers on record are StemCyte, AlphaCord, Cryo-Cell International, ViaCord and Cord Blood Registry (CBR). Regional players are Cells4Life and Smart Cells International. Celularity Inc. is listed as a broad incumbent. Emerging players are Cleveland Cord Blood Center and New York Blood Center.
Does Lifebank have an API?
No public API is recorded for Lifebank.
What industry is Lifebank in?
Lifebank's product category is Stem Cell Banking. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue), with a secondary code of HLAAABAE, Stem Cell Therapies (MSC/iPSC/HSC-derived). Its NAICS code is 621991 and its SIC code is 2836.